DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Concert Pharmaceuticals, Inc. (CNCE)
« Back to company indexCNCE Chatter Timeline
Stock Ticker for CNCE
Most Active Tweeters for CNCE
| User | Tweets |
|---|---|
| @Tickeron | 8 |
| @TickerReport | 3 |
| @StockNewsNow | 2 |
| @WeekHerald | 2 |
| @dakotafinancial | 2 |
Recent Tweets for CNCE
 |
@MaisaCorp $CNCE completed enrollment in a clinical study which aims to determine the efficacy and tolerability of once-daily… https://t.co/OGs4HKpYpo September 17th 2019, 4:09pm |
 |
@StockNewsNow $CNCE Concert Pharmaceuticals Completes Enrollment in Second Open Label Trial of CTP-543 to Evaluate Once-Daily vs.… https://t.co/8VA8a0GmRU September 17th 2019, 11:09am |
 |
@ProTradersNews $CNCE: Patient enrollment completed in Concert Pharma’s CTP-543 trial for …: https://t.co/VdM7suLYeO September 17th 2019, 8:09am |
 |
@MarketCurrents $CNCE - Patient enrollment completed in Concert Pharma's CTP-543 trial for alopecia areata https://t.co/2KfQoQqEpE September 17th 2019, 7:09am |
 |
@newswithvalue $CNCE: Concert Pharmaceuticals Completes Enrollment in Second Open …: https://t.co/jCEHQGQDth September 17th 2019, 7:09am |
 |
@portefeuillefun $CNCE. https://t.co/660270VCnT September 17th 2019, 7:09am |
 |
@dakotafinancial Savara $SVRA vs. Concert Pharmaceuticals $CNCE Head-To-Head Review https://t.co/NOvqeLy8zq September 17th 2019, 5:09am |
 |
@Tickeron $CNCE in Downtrend: 50-day Moving Average moved below 200-day Moving Average on June 5, 2018. View odds for this an… https://t.co/v5ccUeuHTR September 17th 2019, 4:09am |
 |
@TickerReport Concert Pharmaceuticals $CNCE Downgraded by ValuEngine https://t.co/FwUnKONzIn September 16th 2019, 4:09am |
|
@TickerReport Savara $SVRA vs. Concert Pharmaceuticals $CNCE Head-To-Head Contrast https://t.co/Zx0EQbOub8 September 15th 2019, 4:09am |
|
@Tickeron $CNCE in Downtrend: 50-day Moving Average moved below 200-day Moving Average on June 5, 2018. View odds for this an… https://t.co/VryY7iAiiF September 14th 2019, 6:09am |
 |
@WeekHerald Concert Pharmaceuticals $CNCE Downgraded to Hold at ValuEngine https://t.co/XWHJ0ucFUM September 13th 2019, 5:09pm |
 |
@ThisLincolnian Concert Pharmaceuticals $CNCE Downgraded by ValuEngine https://t.co/FKLpz8jiR5 September 13th 2019, 5:09pm |
|
@Tickeron $CNCE in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/jvYB4l5dLR September 13th 2019, 3:09am |
|
@dakotafinancial Concert Pharmaceuticals $CNCE Downgraded by ValuEngine to “Hold” https://t.co/hu2A7QYqLj September 13th 2019, 12:09am |
 |
@SeekingAlpha $CNCE - Concert Gears Up For Late-Stage Study After Showing It Has The Goods For Treating Hair Loss https://t.co/hQPQQ09GxC September 12th 2019, 1:09pm |
|
@StockNewsNow $CNCE Concert Pharmaceuticals Announces CTP-543 Phase 2 Alopecia Areata Data Selected for Late-Breaker Oral Present… https://t.co/L5vmVynqWT September 12th 2019, 10:09am |
 |
@ProVesting $CNCE: Concert Pharmaceuticals Announces CTP-543 Phase 2 Alopecia …: https://t.co/JINU4ZftJj September 12th 2019, 7:09am |
|
@Tickeron $CNCE in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/c4QJJkhAqu September 12th 2019, 4:09am |
 |
@AmericanBanking Analysts’ Weekly Ratings Changes for Concert Pharmaceuticals $CNCE https://t.co/EmMO4s88hG #stocks September 11th 2019, 8:09pm |
 |
@WatchlistN Analysts’ Weekly Ratings Changes for Concert Pharmaceuticals $CNCE https://t.co/w0Jlfa7pDB September 11th 2019, 8:09pm |
|
@Tickeron $CNCE in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/iwa3esFzd6 September 11th 2019, 3:09am |
|
@SeekingAlpha $CNCE - Concert Pharmaceuticals (CNCE) Investor Presentation - Slideshow https://t.co/xVPfs96YW2 September 10th 2019, 12:09pm |
 |
@Jdalexander64 $CNCE CTP-692 appears to have overcome the safety hurdles of D-serine & D-serine shown to have strong efficacy in s… https://t.co/9pnJ3KNUnh September 10th 2019, 6:09am |
|
@Tickeron $CNCE in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/PQekXB4bky September 10th 2019, 3:09am |
 |
@Mholdify RT @ConcertPharma: $CNCE will be presenting today at the H.C. Wainwright Conference #HCWCO at 8:45 a.m. ET. Listen here: https://t.co/8BFtm… September 9th 2019, 8:09am |
 |
@ConcertPharma $CNCE will be presenting today at the H.C. Wainwright Conference #HCWCO at 8:45 a.m. ET. Listen here:… https://t.co/XqOcCc8RAy September 9th 2019, 6:09am |
|
@TickerReport Concert Pharmaceuticals $CNCE Upgraded by BidaskClub to Hold https://t.co/FOg3YQ0vu7 September 9th 2019, 4:09am |
|
@Tickeron $CNCE in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/Q1m1BdBc1v September 9th 2019, 2:09am |
 |
@dailypoliticaln Concert Pharmaceuticals Inc $CNCE Receives Average Recommendation of “Buy” from Brokerages https://t.co/DMsZO2AtbZ September 8th 2019, 9:09pm |
 |
@ZolmaxNews Concert Pharmaceuticals Inc $CNCE Receives Average Rating of “Buy” from Brokerages https://t.co/LcA6bArm6q September 8th 2019, 9:09pm |
 |
@macondailynews Concert Pharmaceuticals $CNCE Stock Rating Upgraded by BidaskClub https://t.co/ddNWdJobKx September 8th 2019, 3:09pm |
 |
@TheMarketsDaily Concert Pharmaceuticals $CNCE Lifted to “Hold” at BidaskClub https://t.co/cjqeI6viCr September 8th 2019, 3:09pm |
 |
@ConsumerFeed Concert Pharmaceuticals $CNCE PT Raised to $29.00 at Mizuho https://t.co/jbsWcEE0Fl September 8th 2019, 1:09pm |
|
@Tickeron $CNCE in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/LTMowmjsZF September 8th 2019, 3:09am |
 |
@TranscriptDaily Concert Pharmaceuticals $CNCE Upgraded at ValuEngine https://t.co/YTj9ombX9e September 8th 2019, 2:09am |
|
@ThisLincolnian Concert Pharmaceuticals $CNCE Upgraded at ValuEngine https://t.co/ALilZHZIa6 September 8th 2019, 2:09am |
 |
@registrarjourn Concert Pharmaceuticals $CNCE Upgraded at ValuEngine https://t.co/obvOZmXG5x September 8th 2019, 2:09am |
 |
@EnterpriseLeade Concert Pharmaceuticals $CNCE Upgraded at ValuEngine https://t.co/SiZWUzF542 September 8th 2019, 2:09am |
|
@WeekHerald Concert Pharmaceuticals $CNCE Upgraded at ValuEngine https://t.co/kmqK34F3Rl September 7th 2019, 9:09am |
 |
@OlympiaReport Mizuho Boosts Concert Pharmaceuticals $CNCE Price Target to $29.00 https://t.co/qDFiAPMI8N September 7th 2019, 9:09am |
 |
@stocknewstimes Concert Pharmaceuticals $CNCE Upgraded at Zacks Investment Research https://t.co/KXfN0ldRTp August 11th 2019, 2:08pm |
|
@TranscriptDaily Concert Pharmaceuticals $CNCE Upgraded at Zacks Investment Research https://t.co/ZTppUwZBgI August 11th 2019, 2:08pm |
|
@dakotafinancial Concert Pharmaceuticals $CNCE Rating Lowered to Hold at ValuEngine https://t.co/ToSBP1X98H August 11th 2019, 1:08pm |
|
@WeekHerald Concert Pharmaceuticals $CNCE Stock Rating Lowered by ValuEngine https://t.co/2YX9TsCGFh August 10th 2019, 7:08pm |
|
@ThisLincolnian Concert Pharmaceuticals $CNCE Stock Rating Lowered by ValuEngine https://t.co/sP7u0YB5JL August 10th 2019, 7:08pm |
|
@dakotafinancial Concert Pharmaceuticals $CNCE Upgraded to “Buy” at Zacks Investment Research https://t.co/oaDto7Llfv August 10th 2019, 6:08pm |
|
@Tickeron $CNCE's Aroon indicator reaches into Uptrend on August 8, 2019. View odds for this and other indicators:… https://t.co/6NK1IQCOtr August 10th 2019, 3:08am |
 |
@dispatchtribune Concert Pharmaceuticals $CNCE Downgraded by ValuEngine to Hold https://t.co/GCLhwBJpNN August 9th 2019, 6:08pm |
|
@registrarjourn Concert Pharmaceuticals $CNCE Downgraded by ValuEngine to Hold https://t.co/wYAl4L5wrv August 9th 2019, 6:08pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.